R. Bals (Marburg, Germany), R. A. Stockley (Birmingham, United Kingdom)
Polymorphisms associated with lung cancer are closely related to COPD
M. V. Vasilyeva, N. V. Cherdyntseva, P. A. Gervas, V. A. Belyavskaya, M. B. Freidin (Tomsk, Kol‘tsovo, Novosibirsk Region, Russian Federation)
|  |
Standardized quantification of pulmonary fibrosis in histological samples
R. H. Huebner, W. Gitter, K. Klase, M. Both, N. E. El Mokhtari, F. Sandra, R. Michael, B. Burkhard (Kiel, Schleswig-Holstein, Germany)
| |
Inhaled budesonide/formoterol combination therapy significantly attenuates allergen-induced increases in airway myfibroblasts
M. Kelly, T. O‘Connor, R. Leigh, J. Otis, G. Gauvreau, J. Gauldie, P. O‘Byrne (Hamilton, ON, Canada)
| |
Endothelin and endothelin receptor A in lymphangioleiomyomatosis
M. Funke, A. Gazdhar, J. M. Fellrath, P. M. Soccal, M. Gugger, R. Lazor, L. P. Nicod, T. Geiser (Bern, Lausanne, Geneva, Switzerland)
|  |
Matrix metalloproteinases (MMPs) and angiogenesis in lung tissue remodeling in different variants of idiopathic interstitial pneumonia (IIP)
E. Kogan, S. Demoura, V. Tuong (Moscow, Russian Federation)
| |
Severe asthma and gastroesophageal reflux: morphofunctional mechanisms of interaction
R. I. Pleshko, L. M. Ogorodova, E. A. Gereng (Tomsk, Russian Federation)
| |
Similarities and discrepancies in oxidative and nitrosative stress in severe COPD and post-infarction chronic heart failure
A. Di Stefano, I. Gnemmi, M. Carbone, E. Eleuteri, A. Capelli, F. L. M. Ricciardolo, M. Colombo, P. Giannuzzi, B. Balbi (Veruno (NO), Torino, Italy)
| |
Surfactant protein-A (SP-A) expression in COPD
E. Vlachaki, E. Tzortzaki, A. Koutsopoulos, K. Dambaki, A. Moniakis, I. Drositis, G. Kimasidis, N. Tzanakis, G. Maltezakis, N. Siafakas (Heraklion, Greece)
| |
Perforin expression in lung tissue of COPD patients: preliminary results
E. Vlachaki, A. Koutsopoulos, K. Dambaki, E. Tzortzaki, N. Tzanakis, I. Drositis, G. Maltezakis, N. Siafakas (Herakion, Heraklion, Greece)
| |
Expression of bradykinin B2 receptor (B2R) and vascular endothelial growth factor (VEGF) in asthma and COPD
F. Sabatini, I. Gnemmi, V. De Rose, G. A. Rossi, B. Balbi, A. Di Stefano, F. L. M. Ricciardolo (Genoa, Veruno (NO), Turin, Italy)
| |
Changes of plasma von Willebrand factor in patients with COPD
N. Karoli, A. Rebrov (Saratov, Russian Federation)
| |
Hyperergic reactions on Helicobacter pylori infection in patients with asthma contributes to stomach mucosa damage
R. I. Pleshko, I. V. Sukhodolo, L. M. Ogorodova, A. N. Dzuman (Tomsk, Russian Federation)
| |
CXCL12 expression in malignant mesothelioma
Y. Shimizu, K. Dobashi, H. Imai, N. Sunaga, A. Ono, K. Kaira, N. Yanagitani, T. Hisada, T. Ishizuka, M. Utsugi, H. Aoki, M. Mori (Maebashi, Gunma, Japan)
| |
Interleukin-4 and interleukin-5 are increased in asthma early in the course of the disease
S. Baraldo, G. Turato, M. E. Zanin, E. Bazzan, F. Savoia, A. Ballarin, C. Panizzolo, P. Maestrelli, R. Zuin, A. Barbato, M. Saetta (Padova, Italy)
| |
Toll-like receptor 2 gene polymorphisms Arg677Trp and Arg753Gln in sarcoidosis
S. Pabst, V. Yenice, M. Lennarz, C. Grohé (Bonn, Germany)
| |
Serum levels of IL-10 and IL-12p40 in pulmonary sarcoidosis
G. Lombardo, P. Quattrocchi, E. Arena, G. R. Lombardo, A. Carni‘, L. Giannetto (Messina, Italy)
| |
Cellular biomarkers in chronic obstructive pulmonary disease in radiation exposed
D. Bazyka, L. Shvayko, K. Bazyka (Kiev, Ukraine)
| |
Routine DNA cytometry of pleural effusions: a prospective study
E. C. Mitrofan, C. Mitrofan, F. Zugun (Iasi, Romania)
| |